Mustapha
Mustapha Abarghaz, Wittenheim FR
Patent application number | Description | Published |
---|---|---|
20090215752 | Compounds, preparation and therapeutic use thereof - The invention relates to benzodiazepine derivatives having PDE2 inhibitory activities, as well as therapeutic methods of administering said compounds, in particular for treating various diseases of the central or peripheral nervous system. The invention further includes methods of preparing the subject compounds and pharmaceutical compositions containing them. | 08-27-2009 |
Mustapha Abbad, Al-Khobar SA
Patent application number | Description | Published |
---|---|---|
20140054039 | MATERIALS AND METHODS TO PREVENT FLUID LOSS IN SUBTERRANEAN FORMATIONS - Methods of preventing fluid loss in a downhole formation may include preparing an emulsion containing: an oleaginous phase; an aqueous phase; one or more fibers; injecting the emulsion into the wellbore; allowing the one or more fibers within the emulsion to seal a permeable interval of the formation. In another aspect, methods of stimulating hydrocarbon production in a wellbore may include: injecting a diverting treatment into a subterranean formation, the diverting treatment containing: a non-oleaginous fluid, an oleaginous fluid, and one or more fibers; injecting a stimulating treatment into the subterranean formation; and stimulating the production of hydrocarbons. | 02-27-2014 |
20150075272 | EVALUATION OF FLUID-PARTICLE MIXTURES BASED ON DIELECTRIC MEASUREMENTS - A system is described for evaluating coagulation of particles in a downhole fluid-particle mixture based on dielectric measurements. An example downhole treatment is one in which flocs are used to plug a high-permeability subterranean formation zone as part of a stimulation procedure. An injection tube is positioned within the wellbore to the high-permeability zone. An instrumented section of tubing includes one or more dielectric probes that are positioned and configured to make dielectric measurements of the particle-fluid mixture flowing in the tubing or in the annulus. The downhole dielectric measurements are used to indicate whether or not the particle-fluid mixture has the desired structural properties. An operator on the surface can make adjustments in real-time according to the received dielectric measurements. | 03-19-2015 |
20160108697 | Mixing and Injecting Fiber-based Stimulation Fluids - An emulsion is mixed with fibers while the emulsion is moving through a surface tubing using a venturi. The fiber/emulsion mixture is injected into a pressurized tank and the pressurized fiber/emulsion mixture is injected from the pressurized tank into a desired location in a wellbore. Pumps and pressure boosters may be used to move the fluid. Alternatively, an emulsion and a fiber suspension is provided and a first downhole tubing disposed in a wellbore conveys the emulsion downhole while a second downhole tubing disposed in the wellbore and circumferentially enclosing all or part of the first downhole tubing conveys the fiber suspension downhole. The first downhole tubing has nozzles through which the emulsion passes into the second downhole tubing and the emulsion and the fiber suspension mix. The mixture exits the second downhole tubing through ports at a desired location in the wellbore. | 04-21-2016 |
Mustapha Aboulcaid, Villejuif FR
Patent application number | Description | Published |
---|---|---|
20150191877 | METHOD FOR BUILDING STRUCTURES, PARTICULARLY PASSAGES UNDER OPERATING RAILWAYS OR THE LIKE - Method for building structures, particularly passages under operating railways or the like. The invention relates to a method for considerably reducing the occurrence and duration of temporary service interruptions required for building underpasses. After temporarily interrupting service on the tracks ( | 07-09-2015 |
Mustapha Aouidate, Laval CA
Patent application number | Description | Published |
---|---|---|
20090062255 | TUMOR-TARGETING EVALUATION METHODOLOGY AND COMPOUNDS RELATED THERETO - The invention relates to a method for evaluating a chemotherapeutic potential of a candidate molecule. In evaluating the candidate molecule, the candidate molecule is tested for its ability to inhibit the in vitro growth of a cancer cell; to bind a cellular receptor produced by a cancer cell, wherein said receptor, such as a peripheral benzodiazepine receptor, is produced in a greater amount by said cancer cell than by a normal cell; and to inhibit the activity of at least one protein member of the MAPK pathway. The invention further relates to dibenzodiazepinone analogues and derivatives thereof. | 03-05-2009 |
Mustapha Barakate, Marrakech MA
Patent application number | Description | Published |
---|---|---|
20110143940 | STREPTOMYCES BETA-VULGARIS STRAIN, CULTURE FILTRATE, DERIVED ACTIVE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF PLANTS | 06-16-2011 |
20130059729 | STREPTOMYCES BETA-VULGARIS STRAIN, CULTURE FILTRATE, DERIVED ACTIVE COMPOUNDS AND USE THEREOF IN THE TREATMENT OF PLANTS - A method of stimulating the natural defense system of a plant utilizing an isolated strain of | 03-07-2013 |
Mustapha Benkhaira, La Chaux-De-Fonds CH
Patent application number | Description | Published |
---|---|---|
20090246546 | METHOD FOR PRODUCING A PLASTIC MEMBRANE DEVICE AND THE THUS OBTAINED DEVICE - A method for producing a membrane device by providing a substrate ( | 10-01-2009 |
Mustapha Bennai, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20120257585 | COGNITIVE WIFI RADIO NETWORK - The invention relates to a cognitive radio (CR) WiFi network which includes a plurality of radio environment aware WiFi terminals, which collect local WiFi interference information and send this information to a CR network management system (NMS). The CR NMS includes a database for storing historical records of the interference information obtained from the terminals, and cognitive engines for analyzing the stored historical interference records and determining terminal-specific transmission and reception parameters. In one embodiment the network implements a deterministic NMS-directed networks-wide TDD/TDM scheduling of WiFi communications for optimal channel re-use and interference avoidance, and a novel terminal synchronization mechanism. | 10-11-2012 |
Mustapha Benomar, Duisburg DE
Patent application number | Description | Published |
---|---|---|
20080197315 | Siloxane-Containing Formulation for Reducing Crease Formation - Compositions comprising at least one aminoalkylsiloxane and at least one higher alkyl-modified amido aminosiloxane modified by a compound having at least two hydroxyl groups selected from the group consisting of hydroxycarboxylic acids, monosaccharides, disaccharides and mixtures thereof are described along with fabric treatment agents containing such compositions, the use of such compositions and agents for treating fabrics, and containers with such compositions and/or agents. | 08-21-2008 |
20130023603 | EPOXY RESIN COMPOSITION WITH REDUCED TOXICITY - The subject matter of the present Application is two-component compositions whose first component is a mixture of reactive epoxy resins and optionally further formulation constituents which contains, based on the mass of all epoxy resins, | 01-24-2013 |
20130056151 | ONE COMPONENT EPOXY RESIN COMPOSITION - The present invention relates to heat-curable compositions containing a mixture of reactive epoxy resins that contains, based on the mass of all epoxy resins, a) at least 10 wt % of an epoxy group-containing reaction product of epichlorohydrin with polypropylene glycol which has an epoxy equivalent weight of at least 250 g/eq, and b) at least 10 wt % of an epoxy group-containing reaction product of epichlorohydrin with a novolac resin which has an epoxy equivalent weight of at least 175 g/eq, and at least one latent hardener. | 03-07-2013 |
20130146223 | HARDENER FOR EPOXY RESINS - The present application is directed to use of a thioether compound, obtainable from a first educt that comprises at least two thiol groups and from a second educt that comprises at least one α,β-unsaturated amide group as well as at least one tertiary amine group, for the hardening of reactive resins. | 06-13-2013 |
Mustapha Boubcher, Burlington CA
Patent application number | Description | Published |
---|---|---|
20130202076 | NUCLEAR FUEL BUNDLE CONTAINING THORIUM AND NUCLEAR REACTOR COMPRISING SAME - Fuel bundles for a nuclear reactor are disclosed, and in some embodiments include a first fuel element including thorium dioxide; a second fuel element including uranium having a first fissile content; and a third fuel element including uranium having a second fissile content different from the first fissile content. Nuclear reactors using such fuel bundles are also disclosed, including pressurized heavy water nuclear reactors. The uranium having the different fissile contents can include combinations of natural uranium, depleted uranium, recycled uranium, slightly enriched uranium, and low enriched uranium. | 08-08-2013 |
20130266112 | NUCLEAR FUEL CONTAINING RECYCLED AND DEPLETED URANIUM, AND NUCLEAR FUEL BUNDLE AND NUCLEAR REACTOR COMPRISING SAME - Nuclear fuels for nuclear reactors are described, and include nuclear fuels having a first fuel component of recycled uranium, and a second fuel component of depleted uranium blended with the first fuel component, wherein the blended first and second fuel components have a fissile content of less than 1.2 wt % of | 10-10-2013 |
20130301780 | NUCLEAR FUEL CONTAINING A NEUTRON ABSORBER - Fuel bundles for a nuclear reactor are described and illustrated, and in some cases include fuel elements each having a fissile content of | 11-14-2013 |
20130308741 | NUCLEAR FUEL CONTAINING RECYCLED AND DEPLETED URANIUM, AND NUCLEAR FUEL BUNDLE AND NUCLEAR REACTOR COMPRISING SAME - Fuel bundles for a nuclear reactor are described and illustrated, and in some cases includes fuel elements each having a first fuel component of recycled uranium; and a second fuel component of at least one of depleted uranium and natural uranium blended with the first fuel component, wherein the blended first and second fuel components have a first fissile content of less than 1.2 wt % of | 11-21-2013 |
Mustapha Chelloug, Echirolles FR
Patent application number | Description | Published |
---|---|---|
20120242358 | Method and Device for Performing Diagnostics of an Actuator, and Actuator Comprising One Such Device - A diagnostic method of an actuator comprising a coil and a control device of power supply of the coil, comprising the following steps: | 09-27-2012 |
Mustapha Chouiki, Linz AT
Patent application number | Description | Published |
---|---|---|
20150293442 | METHOD FOR MICROCONTACT PRINTING - A method for microcontact embossing of a structure by transferring an embossing material onto a target surface of a substrate by means of an embossing surface of a structural die. The embossing material is comprised at least predominantly of silane or at least predominantly of at least one silane derivative and in that the structural die is a soft die. A corresponding method is provided in which the embossing material is a molecular component that is comprised at least predominantly of organic molecules. | 10-15-2015 |
20160136873 | EMBOSSING COMPOUND FOR EMBOSSING LITHOGRAPHY - An embossing material that can be hardened and used for embossing lithography, comprised of a mixture of: at least one polymerizable main component, and at least one secondary component. The invention also relates to a use of the embossing material for the primary forming of an embossing form. | 05-19-2016 |
Mustapha El Haddouchi, Lille FR
Patent application number | Description | Published |
---|---|---|
20120121036 | METHOD AND APPARATUS FOR CLOCK SPUR SUPPRESSION IN DIRECT-RF MODULATORS - Methods and systems to reduce clock spurs produced by a direct-RF modular to acceptable levels using a digital predistortion compensation signal. The digital compensation signal may be used to generate a sine wave in the digital domain with adjustable phase and amplitude. The digital compensation signal may be added to a digital signal processor (DSP) section of an upconvertor, and may be combined with the undesired clock spur signal to reduce it or even cancel it out completely. In some implementations, the digital predistortion compensation signal may have a similar level of the clock spur such that when added to the clock spur, results in a clock spur having a reduced amplitude. | 05-17-2012 |
Mustapha Elmarkhi, Richardson, TX US
Patent application number | Description | Published |
---|---|---|
20140049224 | SYSTEM AND METHOD FOR BALANCING VOLTAGES - A circuit providing voltage cell balancing is provided. The circuit includes a cell balancing network comprising separate switching circuits, each being configured to balance a respective cell voltage for a respective cell of a plurality of voltage cells based on a respective switching control signal. A control circuit includes a plurality of current sources, each of the plurality of current sources selectively connected to a respective one of the separate switching circuits to independently control operation of each of the separate switching circuits of the cell balancing network to balance the voltage across the plurality of voltage cells. | 02-20-2014 |
Mustapha El-Markhi, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20110128659 | LOW POWER LOAD SWICH WITH PROTECTION CIRCUITRY - Load switches are relatively common and in use with a variety of applications, and conventional load switches have been designed to have continually operating protection circuitry, which can consume a great deal of power. Here, a load switch integrated circuit (IC) is provided where a controller within the IC activates and deactivates various protection circuits in a sequence, allowing the protection circuit to protect the IC while also reducing power consumption. | 06-02-2011 |
Mustapha Elyaakoubi, Ris-Orangis FR
Patent application number | Description | Published |
---|---|---|
20090155489 | VOLTAGE NON-UNIFORMITY COMPENSATION METHOD FOR HIGH FREQUENCY PLASMA REACTOR FOR THE TREATMENT OF RECTANGULAR LARGE AREA SUBSTRATES - A vacuum vessel and at least two electrodes define an internal process space. At least one power supply is connectable with the electrodes. A substrate holder holds a substrate to be treated in the internal process space. At least one of the electrodes has along a first cross section a concave profile and has along a second cross section a convex profile, the first cross section being parallel to the second cross section. Gas is provided to the space through a gas inlet. Power is provided to the electrodes and the substrate is treated. | 06-18-2009 |
20100139863 | VOLTAGE NON-UNIFORMITY COMPENSATION METHOD FOR HIGH FREQUENCY PLASMA REACTOR FOR THE TREATMENT OF RECTANGULAR LARGE AREA SUBSTRATES - A vacuum vessel and at least two electrodes define an internal process space. At least one power supply is connectable with the electrodes. A substrate holder holds a substrate to be treated in the internal process space. At least one of the electrodes has along a first cross section a concave profile and has along a second cross section a convex profile, the first cross section being parallel to the second cross section. Gas is provided to the space through a gas inlet. Power is provided to the electrodes and the substrate is treated. | 06-10-2010 |
Mustapha Ennaji, Munchen DE
Patent application number | Description | Published |
---|---|---|
20110190963 | METHOD AND SYSTEM FOR AN OPTIMIZED UTILIZATION OF ENERGY RESOURCES OF AN ELECTRICAL SYSTEM - A method for optimized utilization of available energy resources/sources ( | 08-04-2011 |
Mustapha Guesmia, West Henrietta, NY US
Patent application number | Description | Published |
---|---|---|
20130107290 | PRINTER CALIBRATION USING A SCANNER | 05-02-2013 |
20140009769 | ENABLING OPTIMAL USE OF NON-STANDARD COLORANTS - Methods and systems receive a print job and determine whether the print job specifies one or more extended gamut color marking materials. The extended gamut color marking materials comprise marking materials having colorants other than standard colorants. The standard colorants consist of cyan, magenta, yellow, black (CMYK). When the print job does not specify one or more of the extended gamut color marking materials, the methods and systems determine whether the print job will perform better with one or more of the extended gamut colorants in addition to the standard colorants. The methods and systems print the print job use the extended gamut colorant(s) and the standard colorants when the print job specifies the extended gamut color marking material, and when the print job will perform better with one or more of the print system's extended gamut colorants in addition to the standard colorants. | 01-09-2014 |
Mustapha Guesmia, Rochester, NY US
Patent application number | Description | Published |
---|---|---|
20080266590 | PAD PRINTING USER INTERFACE DIALOG FOR COPY OR PRINT - A method and graphical user interface for selecting pad printing functions for an image output device. The user interface is provided to a user and displays a pad printing dialog box that enables selection of pad printing output. Selectable pad printing options are displayed, which include the number of sheets per pad and the total number of pads to be output. When the user selection of pad printing and pad printing options are received, the total quantity of sheets to be output based on selected pad printing options and organizing the sheets for pad printing output from the image output device are automatically determined. Availability of pad printing is determined based on finishing options selected. | 10-30-2008 |
Mustapha Haddach, San Deigo, CA US
Patent application number | Description | Published |
---|---|---|
20110218184 | QUINOLONE ANALOGS AND METHODS RELATED THERETO - The present invention provides novel quinolone compounds and pharmaceutical composition thereof which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing such compounds and compositions, and methods of making and using the same. | 09-08-2011 |
Mustapha Hayouna, Phoenix, AZ US
Patent application number | Description | Published |
---|---|---|
20090042665 | Composite Golf Club Hosels and Methods of Use Thereof - Embodiments of composite golf club hosels and methods of use thereof are generally described herein. In one embodiment, a golf club includes a golf club shaft and a hollow body. The body has a heel end, a toe end, a front wall, a sole, and a crown. The heel end of the crown includes a hosel for receiving the golf club shaft, and the hosel is at least partially comprised of a composite material. Other embodiments may be described and claimed. | 02-12-2009 |
Mustapha Karime, Riyadh SA
Patent application number | Description | Published |
---|---|---|
20150139896 | SOLAR ENERGY BASED COUNTINUOUS PROCESS AND REACTOR SYSTEM FOR THE PRODUCTION OF AN ALKENE BY DEHYDROGENATION OF THE CORRESPONDING ALKANE - A solar energy based continuous process and reactor system for the production of an alkene by dehydrogenation of the corresponding alkane is performed in a reactor which process comprises alternatingly performing a first mode and a second mode in the same reactor, wherein the first mode is a non-oxidative dehydrogenation wherein the non-oxidative dehydrogenation is performed by contacting the alkane with a suitable dehydrogenation catalyst at a temperature of at least 500° C. to produce the corresponding alkene and hydrogen and wherein the second mode is an oxidative dehydrogenation wherein the oxidative dehydrogenation is performed by contacting the alkane with a suitable dehydrogenation catalyst and an oxidation agent at a temperature from 300 to 500° C. to produce the corresponding alkene wherein the dehydrogenation catalyst for the oxidative dehydrogenation and the non-oxidative dehydrogenation are the same, wherein the heat for the first mode is provided by a solar energy source. | 05-21-2015 |
Mustapha Ladjali, Rueil Malmaison FR
Patent application number | Description | Published |
---|---|---|
20160128832 | DEVICE FOR TREATMENT OF BODY TISSUE, AND ASSOCIATED TREATMENT KIT - A device for treating a body tissue having a prolapse comprising two clamping assemblies, each clamping assembly being able to clamp a free edge of the body tissue on either side of the prolapse, and a membrane connecting both clamping assemblies to each other, the membrane being able to be held taut facing the prolapse by both clamping assemblies, is provided herein. | 05-12-2016 |
Mustapha Ladjali, Sannois FR
Patent application number | Description | Published |
---|---|---|
20160038149 | BODILY TISSUE TREATMENT KIT - The invention relates to a clamp for treating a bodily tissue having a prolapse, the clamp including a body and at least two flexible arms for clamping the prolapse protruding with respect to the body, each clamping arm comprising a proximal end connected to the body and a free distal end opposite to the proximal end. The clamp includes at least one flexible member for crushing the prolapse, the crushing member protruding from the body or from one of the arms. | 02-11-2016 |
Mustapha Laribi, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20100121292 | POTTY TRAINING INSERT FOR DIAPER AND COMBINATION THEREOF - A potty training insert for a diaper and a combination thereof is provided. The potty training insert comprises a sensor and a detector. The sensor is adapted to be coupled to the diaper. The sensor comprises a pair of electrically conductive cloth strips adjacent to each other and a pair of insulative layers sandwiching the pair of electrically conductive cloth strips. The detector is operatively coupled to the pair of electrically conductive cloth strips of the sensor. The detector is adapted to produce a customized alarm signal when the pair of electrically conductive cloth strips senses moisture in the diaper. The customized alarm signal enables a child to restrain excretory movements for becoming potty trained. | 05-13-2010 |
Mustapha Lebbah, Aubervilliers FR
Patent application number | Description | Published |
---|---|---|
20120131026 | VISUAL INFORMATION RETRIEVAL SYSTEM - A system for information retrieval within a database of large size includes a first module for extracting the descriptors associated with each object in the database, and for constructing a table containing the objects and the value of a descriptor associated with an object. The system also includes a second module for applying a number of classification algorithms, for each of the tables obtained from the module, a third module to fusion the results obtained from the module in order to determine, for each type of descriptor, a class number associated with an object, a fourth module for finding which column of a table is closest to the column obtained during the first fusion of the step, and for selecting the map that is closest contained in the table, or best map, and a fifth module to fusion the aggregate “best maps”, and applying an algorithm for searching for the best map to be transmitted to a display means. | 05-24-2012 |
Mustapha Lejri, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20140067269 | UNDISTURBED FRACTURE ORIENTATION - A method can include providing fault geometry data and fracture data for a fracture; estimating a parameter value of a far field stress based at least in part on the fault geometry data and the fracture data; and determining an undisturbed parameter value for the fracture. Various other apparatuses, systems, methods, etc., are also disclosed. | 03-06-2014 |
Mustapha Lejri, Grabels FR
Patent application number | Description | Published |
---|---|---|
20150205006 | DOWNHOLE MODELING USING INVERTED PRESSURE AND REGIONAL STRESS - Systems and methods for predicting a stress attribute of a subsurface earth volume. One or more linearly independent far field stress models and one or more discontinuity pressure models may be simulated for the subsurface earth volume to generate stress values, strain values, displacement values, or a combination thereof for data points in the subsurface earth volume. A processor may be used to compute a superposition of the one or more linearly independent far field stress models and the one or more discontinuity pressure models. The stress attribute of the subsurface earth volume may be predicted, based on the computed stress values, strain values, displacement values, or the combination thereof. | 07-23-2015 |
Mustapha Lemiti, Lyon FR
Patent application number | Description | Published |
---|---|---|
20130112260 | METHOD FOR PREPARING AN N+PP+ OR P+NN+ STRUCTURE ON SILICON WAFERS - The present invention relates to a method for preparing, on a silicon wafer, an n+pp+ or p+nn+ structure which includes the following consecutive steps: a) on a p or n silicon wafer ( | 05-09-2013 |
20140255973 | METHOD FOR DETECTING THE INTERACTION OF AT LEAST ONE ENTITY WITH A DIELECTRIC LAYER - The invention relates to a method of detecting the interaction between at least one entity and a dielectric layer containing different electron levels in the energy band gap of the dielectric layer, the method comprising the following steps: | 09-11-2014 |
Mustapha Najimi, Bruxelles BE
Patent application number | Description | Published |
---|---|---|
20130302291 | COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION - The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one antithrombin activator, preferably unfractionated heparin, as well as at least one thrombin inhibitor, preferably bivalirudin. | 11-14-2013 |
20150037291 | COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION - The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin. | 02-05-2015 |
20160129047 | CONDITIONED MEDIUM FROM HUMAN ADULT LIVER STEM CELLS AND ITS USE IN THE TREATMENT OF LIVER DISORDERS - The invention relates to cell-free compositions obtained by culturing adult-derived human liver stem/progenitor cells (ADHLSC) in cell culture medium and isolating the resulting conditioned medium (ADHLSC-CM) that has advantageous property ties, such as anti-fibrotic effects. ADHLSC-CM, compositions based on ADHLSC-CM, and other related and derived products, can be used in cell culture processes or as a medicament, more particularly for the treatment of diseases involving organ injury, organ failure, in organ or cell transplantation or the pathological disruption, inflammation, degeneration, and/or proliferation of cells within a tissue or an organ, in particular within liver. | 05-12-2016 |
Mustapha Najimi, Woluwe Saint-Lambert BE
Patent application number | Description | Published |
---|---|---|
20080311094 | Isolated Liver Stem Cells - Isolated liver progenitor stem cells and cell populations of isolated liver progenitor stem cells are disclosed. The progenitor stem cells originate from adult liver, especially human adult liver. The isolated progenitor stem cells have uses in medicine, hepatology, inborn errors of liver metabolism transplantation, infectious diseases and liver failure. Methods of isolating these cells and their culture is described. The isolated cells are characterized before and after differentiation. Their use for transplantation and as animal models of human disease, toxicology and pharmacology is disclosed. | 12-18-2008 |
20140127676 | ISOLATED LIVER STEM CELLS - A method of conducting in vitro toxicity testing is disclosed which includes the steps of exposing to a test agent a population of human liver progenitor or stem cells originated from human adult liver. The cells have the characteristics that the isolated human progenitor or stem cells express at least the mesenchymal markers vimentin and α-smooth muscle actin (ASMA), the hepatocyte marker albumin (ALB), are negative for cytokeratin-19 (CK-19), and have mesenchymal-like morphology. One or more effects, if any, of the test agent on the population of human liver progenitor or stem cells are observed. Also disclosed are methods of conducting in vitro drug metabolism studies by exposing to a test agent a population of the human liver progenitor or stem cells and methods of testing infected human liver progenitor or stem cells for effects of a test agent. | 05-08-2014 |
20140286917 | ISOLATED LIVER STEM CELLS - Isolated liver progenitor stem cells and cell populations of isolated liver progenitor stem cells are disclosed. The progenitor stem cells originate from adult liver, especially human adult liver. The isolated progenitor stem cells have uses in medicine, hepatology, inborn errors of liver metabolism transplantation, infectious diseases and liver failure. Methods of isolating these cells and their culture is described. The isolated cells are characterized before and after differentiation. Their use for transplantation and as animal models of human disease, toxicology and pharmacology is disclosed. | 09-25-2014 |
20150306147 | ISOLATED LIVER STEM CELLS - A method of treating liver-based inborn, metabolic deficiencies is disclosed by treatment of an individual, such as a patient suffering from liver-based inborn, metabolic deficiencies, with human progenitor or stem cells, a cell population or their progeny. The cells used in the treatment have the following characteristics. They are positive for vimentin, α-smooth muscle actin (ASMA), and for at least one mesenchymal marker such as CD90, CD29, CD73, and CD44. They are positive for at least one hepatocyte marker such as albumin, alpha-fetoprotein, alpha-1 antitrypsin, HNF-4 and MRP2 transporter. They express at least one hepatocyte-like property or function such as G6P, CYP1B1, CYP3A4, TDO, TAT, GS, GGT, CK8, and EAAT2. They are negative for at least one marker such as cytokeratin-19, CD45, CD34, CD49f, CD133, HLA-DR, and CD117. They have mesenchymal-like morphology. They originate from human adult liver cells. | 10-29-2015 |
Mustapha Slamani, South Burlington, VT US
Patent application number | Description | Published |
---|---|---|
20130226499 | CIRCUIT TEST SYSTEM AND METHOD USING A WIDEBAND MULTI-TONE TEST SIGNAL - Disclosed are a testing system and method incorporating a test signal generator for generating a test signal with multiple tones uniformly distributed across a wideband having a specific bandwidth. This test signal is generated based on user-specified test signal parameter(s) (e.g., using an orthogonal frequency-division multiplexing (OFDM) spread spectrum technique) and processed (e.g., converted from digital to analog or shifted to a different wideband having the same bandwidth), as necessary, so that it is suitable for application to a specific device under test and so that the tones account for the full range of frequencies with the wideband operation of that device under test. After it is applied to the device under test, the resulting output signal is captured, processed (e.g., converted back to digital or shifted back to the initial wideband), as necessary, and analyzed in order to determine the frequency responses associated with each of the tones. | 08-29-2013 |
20140184258 | HIGH POWER RADIO FREQUENCY (RF) IN-LINE WAFER TESTING - Approaches for performing in line wafer testing are provided. An approach includes a method that includes generating a radio frequency (RF) test signal, and applying the RF test signal to a device under test (DUT) in a wafer using a buckling beam probe set with a predefined pitch. The method also includes detecting an output RF signal from the DUT in response to the applying the RF test signal to the DUT, and sensing at least one frequency component of the detected output RF signal. | 07-03-2014 |
Mustapha Soukri, Raleigh, NC US
Patent application number | Description | Published |
---|---|---|
20090099248 | INHIBITORS OF D-AMINO ACID OXIDASE - The present invention provides novel inhibitors of the enzyme D-amino acid oxidase. The compounds of the invention are useful for treating or preventing diseases and/or condition, wherein modulation of D-serine levels, and/or its oxidative products, is effective in ameliorating symptoms. The invention further provides methods of enhancing learning, memory and/or cognition. For example, the invention provides methods for treating or preventing loss of memory and/or cognition associated with neurodegenerative diseases, such as Alzheimer's disease. The invention further provides methods for preventing loss of neuronal function characteristic of neurodegenerative diseases. In addition, methods are provided for the treatment or prevention of neuropsychiatric diseases (e.g., schizophrenia) and for the treatment or prevention of pain and ataxia. | 04-16-2009 |
20100022612 | FUSED HETEROCYCLES - This invention provides fused heterocycles having the formula: | 01-28-2010 |
20100029737 | INHIBITORS OF D-AMINO ACID OXIDASE - The present invention provides novel inhibitors of the enzyme D-amino acid oxidase. The compounds of the invention are useful for treating or preventing diseases and/or condition, wherein modulation of D-serine levels, and/or its oxidative products, is effective in ameliorating symptoms. The invention further provides methods of enhancing learning, memory and/or cognition. For example, the invention provides methods for treating or preventing loss of memory and/or cognition associated with neurodegenerative diseases, such as Alzheimer's disease. The invention further provides methods for preventing loss of neuronal function characteristic of neurodegenerative diseases. In addition, methods are provided for the treatment or prevention of neuropsychiatric diseases (e.g., schizophrenia) and for the treatment or prevention of pain and ataxia. | 02-04-2010 |
20100029741 | FUSED HETEROCYCLES - This invention provides methods of improving cognitive function by administering to a subject a therapeutically effective amount of a fused heterocycle having the formula: | 02-04-2010 |
20100120740 | PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE - The invention relates to prodrugs of fused heterocyclic inhibitors of D-amino oxidase (DAAO) and methods of treating diseases and conditions, wherein modulation of D-amino acid oxidase activity, D-serine levels, D-serine oxidative products and NMDA receptor activity in the nervous system of a mammalian subject is effective. | 05-13-2010 |
20110034434 | PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE - The invention relates to prodrugs of fused heterocyclic inhibitors of D-amino oxidase (DAAO) and methods of treating diseases and conditions, wherein modulation of D-amino acid oxidase activity, D-serine levels, D-serine oxidative products and NMDA receptor activity in the nervous system of a mammalian subject is effective. | 02-10-2011 |
20140066504 | ANALOGS AND PRODRUGS OF BUMETANIDE; COMPOSITIONS AND METHODS OF USE - Novel analogs and prodrugs of the loop diuretic bumetanide are described. Pharmaceutical compositions containing bumetanide analogs and prodrugs are also described. These analogs and prodrugs are particularly useful for the treatment and/or prophylaxis of conditions that involve the NKCC cotransporter family (NKCC1 and NKCC2), or the KCC cotransporter family (KCC1, KCC2, KCC3, KCC4), or GABAa receptors. Such conditions include, but are not limited to anxiety disorders, epilepsy, migraine, non-epileptic seizures, sleep disorders, obesity, eating disorders, autism, depression, edema, glaucoma, stroke, ischemia, neuropathic pain, addictive disorders, schizophrenia, psychosis, and tinnitus. | 03-06-2014 |
20140179746 | AMIDO-PYRIDYL ETHER COMPOUNDS AND COMPOSITIONS AND THEIR USE AGAINST PARASITES - The subject matter disclosed herein is directed to amido-pyridyl ether compounds of formula I: | 06-26-2014 |
20150239832 | ANALOGS AND PRODRUGS OF LOOP DIURETICS, INCLUDING BUMETANIDE, FUROSEMIDE AND PIRETANIDE; COMPOSITIONS AND METHODS OF USE - Novel analogs and prodrugs of the loop diuretics bumetanide, furosemide and piretanide are described. Pharmaceutical compositions containing loop diuretic analogs and prodrugs are also described. These analogs and prodrugs are particularly useful for the treatment and/or prophylaxis of conditions that involve the NKCC cotransporter family (NKCC1 and NKCC2), or the KCC cotransporter family (KCC1, KCC2, KCC3, KCC4), or GABAa receptors. Such conditions include, but are not limited to anxiety disorders, epilepsy, migraine, non-epileptic seizures, sleep disorders, obesity, eating disorders, autism, depression, edema, glaucoma, stroke, ischemia, neuropathic pain, addictive disorders, schizophrenia, psychosis, and tinnitus. | 08-27-2015 |
Mustapha Taffahi, Les Ayvelles FR
Patent application number | Description | Published |
---|---|---|
20150337477 | Method for Controlling a Laundry Washing Machine and Laundry Washing Machine - The present invention relates to a method for controlling a laundry washing machine ( | 11-26-2015 |
Mustapha Tissakht, Montreal CA
Patent application number | Description | Published |
---|---|---|
20140265142 | CARBON SEAL ASSEMBLY - A carbon seal assembly comprises an annular seal runner adapted to be sealingly mounted to a shaft to rotate therewith. An annular member is secured to a structure, the annular member having an annular body and a projection extending from the body toward the seal runner in an axial direction relative to an axis of the runner. A axial gap is defined between the member and the seal runner when secured to the shaft and structure respectively, with the projecting extending into only a portion of the gap, such that the gap defines a first width portion and a second width portion, with the member and the seal runner being made of complementary materials for magnetic attraction therebetween. An annular carbon element is mounted to the seal runner to rotate therewith and positioned in the first width portion of the gap, the carbon element having an annular wear surface abutting against the annular member, a plane of the annular wear surface being axially offset from the second width portion of the gap. | 09-18-2014 |
Mustapha Toutaoui, Berlin DE
Patent application number | Description | Published |
---|---|---|
20140262629 | ELEVATOR SYSTEM WITH MESSAGING FOR AUTOMATED MAINTENANCE - An exemplary elevator system includes a controller that is configured to determine a condition of at least one elevator system component. A message transceiver is coupled with the controller. The message transceiver is configured to send a notification message to a remotely located mobile station that includes an indication of the condition determined by the controller. The message transceiver is configured to receive a response message from the remotely located mobile station that indicates how the controller can address the determined condition. | 09-18-2014 |
20160052747 | PREVENTATIVE MAINTENANCE BY DETECTING LIFETIME OF COMPONENTS - A system for providing preventative maintenance of switchable components includes a load-moving system including one or more switchable components. The system also includes a microcontroller configured to operate the one or more switchable components of the load-moving system, to determine a number of switching events of the one or more switchable components and to perform a preventative maintenance action based on determining that the number of switching events is greater than a threshold number of switching events. | 02-25-2016 |